GlaxoSmithKline Pharmaceuticals has informed that in terms of the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, the trading period for buying or selling of Company’s shares is closed from December 30, 2016 and shall reopen on February 14, 2017 i.e. after the approval and declaration of Un-Audited Financial Results for the third quarter and nine months ended December 31, 2016, by the Board of Directors at its meeting scheduled to be held on February 11, 2017.
The above information is a part of company’s filings submitted to BSE.
